Journal of General Virology,
Год журнала:
2023,
Номер
104(11)
Опубликована: Ноя. 10, 2023
The
recent
coronavirus
disease
2019
(COVID-19)
pandemic
was
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
COVID-19
is
characterized
distress,
multiorgan
dysfunction
and,
in
some
cases,
death.
virus
also
responsible
for
post-COVID-19
condition
(commonly
referred
to
as
‘long
COVID’).
SARS-CoV-2
a
single-stranded,
positive-sense
RNA
with
genome
of
approximately
30
kb,
which
encodes
26
proteins.
It
has
been
reported
affect
multiple
pathways
infected
cells,
resulting,
many
the
induction
‘cytokine
storm’
and
cellular
senescence.
Perhaps
because
it
an
virus,
replicating
largely
cytoplasm,
effect
SARS-Cov-2
on
stability
DNA
damage
responses
(DDRs)
received
relatively
little
attention.
However,
now
becoming
clear
that
causes
DNA,
shown
presence
micronuclei,
repair
foci
increased
comet
tails
cells.
This
review
considers
evidence
indicating
how
instability,
deregulates
cell
cycle
targets
specific
components
DDR
pathways.
significance
virus’s
ability
cause
senescence
considered,
are
implications
instability
patients
suffering
from
long
COVID.
Respirology,
Год журнала:
2023,
Номер
28(11), С. 1005 - 1022
Опубликована: Сен. 16, 2023
Long
COVID,
or
post-acute
COVID-19
sequelae,
is
experienced
by
an
estimated
one
in
eight
adults
following
acute
COVID-19.
COVID
a
new
and
complex
chronic
health
condition
that
typically
includes
multiple
symptoms
cross
organ
systems
fluctuate
over
time;
one-size-fits-all
approach
is,
therefore,
not
likely
to
be
appropriate
nor
relevant
for
long
treatment.
'Treatable
Traits'
personalized
medicine
approach,
purpose-built
address
the
complexity
heterogeneity
of
conditions.
This
comprehensive
review
aimed
understand
how
treatable
traits
could
applied
first
identifying
most
prevalent
then
available
evidence
strategies
target
these
traits.
An
umbrella
22
systematic
reviews
identified
34
complications
common
with
grouped
into
trait
clusters:
neurological,
chest,
psychological,
pain,
fatigue,
sleep
impairment,
functional
impairment
other.
A
randomized
control
trials
18
studies
explored
different
intervention
approaches
prevention
(k
=
4)
management
14).
While
single
study
reported
metformin
as
effective
prevention,
findings
need
replicated
consensus
required
around
define
clinical
trial
endpoint.
For
management,
current
supports
exercise
training
respiratory
muscle
chest
limitation
clusters.
there
are
exploring
interventions
targeting
other
traits,
further
high-quality
RCTs
needed,
particularly
clusters
pain
impairment.
Vaccines,
Год журнала:
2022,
Номер
11(1), С. 74 - 74
Опубликована: Дек. 28, 2022
Mass
vaccination
initiatives
are
underway
worldwide,
and
a
considerable
percentage
of
the
world's
population
is
now
vaccinated.
This
study
examined
association
COVID-19
deaths
per
1000
cases
with
fully
vaccinated
population.
The
global
median
were
15.68
(IQR
9.84,
25.87)
after
6
months
vaccinations
11.96
6.08,
20.63)
12
months.
Across
164
countries,
we
found
significant
variations
in
levels
populations,
booster
doses,
mortality,
higher
vaccine
coverage
lower
mortality
high-income
countries.
Several
regression
models
performed
to
test
between
mortality.
Control
variables
used
account
for
confounding
variables.
A
10-percentage-point
increase
was
associated
an
18.1%
decrease
(95%CI,
7.4-28.8%)
16.8%
6.9-26.7%).
rates
33.1%
16.0-50.2%).
relationship
present
most
analyses
by
country
income
groups
effect
size.
Efforts
needed
reduce
hesitancy
while
ensuring
suitable
infrastructure
supply
enable
all
countries
their
rates.
Journal of Clinical Medicine,
Год журнала:
2023,
Номер
12(10), С. 3511 - 3511
Опубликована: Май 17, 2023
(1)
In
the
present
study,
we
used
data
comprising
patient
medical
histories
from
a
panel
of
primary
care
practices
in
Germany
to
predict
post-COVID-19
conditions
patients
after
COVID-19
diagnosis
and
evaluate
relevant
factors
associated
with
these
using
machine
learning
methods.
(2)
Methods:
Data
retrieved
IQVIATM
Disease
Analyzer
database
were
used.
Patients
at
least
one
between
January
2020
July
2022
selected
for
inclusion
study.
Age,
sex,
complete
history
diagnoses
prescription
before
infection
respective
practice
extracted
each
patient.
A
gradient
boosting
classifier
(LGBM)
was
deployed.
The
prepared
design
matrix
randomly
divided
into
train
(80%)
test
(20%).
After
optimizing
hyperparameters
LGBM
by
maximizing
F2
score,
model
performance
evaluated
several
metrics.
We
calculated
SHAP
values
importance
individual
features,
but
more
importantly,
direction
influence
feature
our
dataset,
i.e.,
whether
it
is
positively
or
negatively
long
COVID.
(3)
Results:
both
sets,
showed
high
recall
(sensitivity)
81%
72%
specificity
80%
80%;
this
offset,
however,
moderate
precision
8%
7%
an
F2-score
0.28
0.25.
most
common
predictive
features
identified
included
variant,
physician
practice,
age,
distinct
number
therapies,
sick
days
ratio,
vaccination
rate,
somatoform
disorders,
migraine,
back
pain,
asthma,
malaise
fatigue,
as
well
cough
preparations.
(4)
Conclusions:
exploratory
study
describes
initial
investigation
prediction
potential
increasing
risk
developing
COVID
electronic
records
learning.
Notably,
development
demographics
their
histories.
European Journal of Pain,
Год журнала:
2023,
Номер
27(9), С. 1107 - 1125
Опубликована: Фев. 28, 2023
Abstract
Background
Pain
after
a
SARS‐CoV‐2
acute
infection
(post‐COVID
pain)
is
becoming
new
healthcare
emergency
but
remains
underestimated
and
most
likely
undertreated
due
to
lack
of
recognition
the
phenomenon
knowledge
underlying
pain
mechanisms.
Evidence
supporting
any
particular
treatment
approach
for
management
post‐COVID
lacking.
Large
variability
in
patient
response
standard
treatments
clinically
observed,
which
has
led
calls
personalized,
tailored
treating
patients
with
chronic
(i.e.
‘precision
medicine’).
Applying
global
concerted
action
towards
precision
medicine
could
help
guide
clinical
decision‐making
aid
more
effective
treatments.
Methods
The
current
position
paper
discusses
factors
be
considered
by
clinicians
managing
ranging
from
identification
phenotype
genetic
consideration.
Results
ability
into
nociceptive,
neuropathic,
nociplastic
or
mixed
type
suggested
as
first
step
better
planification
programme.
Further,
consideration
other
factors,
such
gender,
comorbidities,
received
at
phase
onset‐associated
COVID‐19
symptoms,
during
hospitalization
presence
emotional
disturbances
should
implemented
Conclusions
Accordingly,
considering
these
include
multimodal
pharmacological
non‐pharmacological
modalities
targeting
emotional/cognitive
aspects
psychological
and/or
coping
strategies),
central
sensitization‐associated
mechanisms
neuroscience
education),
exercise
programmes
well
lifestyle
interventions
(e.g.
nutritional
support
sleep
management).
Significance
This
presents
an
evidence‐based
reasoning
pain.
Abstract
Background
Long-term
health
outcomes
in
children
and
young
people
(CYP)
after
COVID-19
infection
are
not
well
understood
studies
with
control
groups
exposed
to
other
infections
lacking.
This
study
aimed
investigate
the
incidence
of
post-COVID-19
condition
(PCC)
incomplete
recovery
CYP
hospital
discharge
compare
between
different
SARS-CoV-2
variants
non-SARS-CoV-2
infections.
Methods
A
prospective
exposure-stratified
cohort
individuals
under
18
years
old
Moscow,
Russia.
Exposed
cohorts
were
paediatric
patients
admitted
laboratory-confirmed
April
2
December
11,
2020
(Wuhan
variant
cohort)
January
12
February
19,
2022
(Omicron
cohort).
respiratory
intestinal
infections,
but
negative
lateral
flow
rapid
diagnostic
test
PCR-test
results
for
SARS-CoV-2,
2022,
served
as
unexposed
reference
cohort.
Comparison
‘exposed
cohorts’
‘reference
cohort’
was
conducted
using
1:1
matching
by
age
sex.
Follow-up
data
collected
via
telephone
interviews
parents,
utilising
long
COVID
protocol
survey
developed
International
Severe
Acute
Respiratory
Emerging
Infection
Consortium
(ISARIC).
The
WHO
case
definition
used
categorise
PCC.
Results
Of
2595
confirmed
COVID-19,
1707
(65.7%)
participated
follow-up
interviews,
1183/1707
(69%)
included
final
‘matched’
analysis.
median
time
post-discharge
6.7
months.
PCC
significantly
higher
Wuhan
(89.7
cases
per
1000
person-months,
95%
CI
64.3–120.3)
compared
post-infection
sequalae
(12.2
4.9–21.9),
whereas
difference
Omicron
significant.
had
rates
dermatological,
fatigue,
gastrointestinal,
sensory,
sleep
manifestations,
behavioural
emotional
problems
than
only
significant
decreased
school
attendance.
When
comparing
cohorts,
event
physical
activity,
deterioration
relationships
observed.
rate
also
both
cohorts.
Conclusions
exhibited
a
propensity
inducing
broad
spectrum
symptoms
changes,
suggesting
pronounced
impact
on
long-term
outcomes.
Conversely,
resulted
fewer
effects
no
from
common
seasonal
viral
illnesses.
may
mean
that
subsequent
might
lead
same
level
consequences
earlier
variants.
Science Translational Medicine,
Год журнала:
2024,
Номер
16(773)
Опубликована: Ноя. 13, 2024
Long
Covid
is
defined
by
a
wide
range
of
symptoms
that
persist
after
the
acute
phase
severe
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection.
Commonly
reported
include
fatigue,
weakness,
postexertional
malaise,
and
cognitive
dysfunction,
with
many
other
reported.
Symptom
range,
duration,
severity
are
highly
variable
partially
overlap
myalgic
encephalomyelitis/chronic
fatigue
post-acute
infectious
syndromes,
highlighting
opportunities
to
define
shared
mechanisms
pathogenesis.
Potential
diverse,
including
persistence
viral
reservoirs,
dysregulated
immune
responses,
direct
damage
tissues
targeted
SARS-CoV-2,
inflammation
driven
reactivation
latent
infections,
vascular
endothelium
activation
or
subsequent
thromboinflammation,
autoimmunity,
metabolic
derangements,
microglial
activation,
microbiota
dysbiosis.
The
heterogeneity
baseline
characteristics
people
Covid,
as
well
varying
states
immunity
therapies
given
at
time
infection,
have
made
etiologies
difficult
determine.
Here,
we
examine
progress
on
preclinical
models
for
review
being
in
clinical
trials,
need
large
human
studies
further
development
better
understand
Covid.
Such
will
inform
trials
treatments
benefit
those
living
this
condition.
Research in Nursing & Health,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 7, 2025
While
the
coronavirus
disease
2019
(COVID-19)
pandemic
has
declined,
many
survivors
continue
to
suffer
debilitating
symptoms,
such
as
fatigue,
pain,
and
foggy
thoughts.
Sustained
COVID-19
or
Long
COVID,
challenge
health
care
resources
economic
recovery.
This
article
describes
methodology,
implementation,
results
of
an
observational
study
investigating
how
time
since
diagnosis
may
affect
lingering
symptoms
among
adult
population.
The
descriptive
distribution
overall
experience
by
individuals'
characteristics
were
examined.
Random
samples
from
two
patient
cohorts
(n
=
147
in
2020-2021
n
137
2021-2022)
recruited
a
registry
mid-Michigan.
Samples
drawn
pool
patients
≥
3
months
following
their
diagnosis.
Overall
(number,
severity,
interference)
was
self-reported
using
comprehensive
symptom
inventory.
findings
showed
that
66%
cohort
47%
2021-2022
reported
1
with
average
11.2
(±3.0)
8.9
(±3.3)
months,
respectively,
after
Females
significantly
more
(p
0.018),
higher
severity
0.008)
interference
0.007)
compared
males.
Compared
admitted
emergency
departments,
outpatients
lower
0.020)
less
0.018).
Our
analyses
moderate
proportion
(43%)
adults
remained
symptomatic
nearly
year
infection
did
not
either
cohort.
Female
sex
admission
setting
are
important
factors
consider
for
managing
studying
COVID.
The
long-term
sequelae
of
coronavirus
disease
2019
(COVID-19)
and
its
recovery
have
becoming
significant
public
health
concerns.
Therefore,
this
study
aimed
to
enhance
the
limited
evidence
regarding
relationship
between
sleep
quality
on
long
COVID
among
older
population
aged
60
years
or
old.
Our
included
4,781
COVID-19
patients
enrolled
from
April
May
2023,
based
Peking
University
Health
Cohort.
Sleep
was
assessed
using
Pittsburgh
Quality
Index
(PSQI)
scale.
Long
evaluated
by
well-trained
professionals
through
patients'
self-reported
symptoms.
Binary
logistic
regression
models
were
employed
calculate
odds
ratios
(OR)
95%
confidence
intervals
(95%
CI).
prevalence
adults
57.4%
(2,743/4,781).
Specifically,
general
symptoms,
cardiovascular
respiratory
gastrointestinal
neurological
psychiatric
symptoms
47.7%
(2,282/4,781),
3.4%
(163/4,781),
35.2%
(1683/4,781),
8.7%
(416/4,781)
5.8%
(279/4,781),
respectively.
For
each
one-point
increase
in
PSQI
scores,
risk
COVID,
increased
3%
CI:
1.01,
1.06),
7%
1.13),
11%
1.07,
1.15),
20%
1.15,
1.25),
In
multivariate
models,
compared
with
good
sleepers,
poor
exhibited
an
(aOR
=
1.17;
1.03,
1.33),
1.50;
1.06,
2.14),
2.03;
1.61,
2.54),
2.57;
CI
1.96,
3.37).
findings
indicate
that
is
related
various
manifestations
populations.
A
comprehensive
assessment
multidisciplinary
management
may
be
essential
ensure
healthy
aging
future.
Healthcare,
Год журнала:
2025,
Номер
13(3), С. 262 - 262
Опубликована: Янв. 29, 2025
Objective:
Since
the
lifting
of
COVID-19
restrictions
in
China
November
2022,
there
has
been
a
notable
surge
infection
rate.
Little
is
known
about
prevalence
long
COVID
among
general
adult
population
and
its
impact
on
COVID-19-related
worries
behaviors
after
policy
change.
Methods:
This
cross-sectional
study
recruited
1530
adults
with
prior
Guangzhou
from
February
to
March
2023.
Logistic
regression
analyses
trend
were
performed
investigate
associations
between
COVID-
preventive
behaviors.
Results:
The
estimated
was
18.0%
(95%
confidence
interval:
16.1%
20.0%).
Common
symptoms
included
cough
(60.7%),
fatigue
(47.6%),
dyspnea
(34.5%),
palpitation
(26.2%),
insomnia
(25.1%).
Adjusted
for
background
variables,
individuals
exhibited
higher
level
compared
those
who
had
fully
recovered
(reference:
without
COVID;
adjusted
odds
ratios
ranged
1.87
2.55,
all
p
values
<
0.001).
Participants
primarily
expressed
regarding
potential
reinfection,
pandemic
daily
life,
increasing
number
cases
deaths,
capacity
healthcare
system.
While
did
not
statistically
significantly
affect
their
Conclusions:
Long
prevalent
restrictions,
it
significant
worries.
highlights
importance
monitoring
mental
health
developing
targeted
intervention
strategies
improve
adherence
measures.